Skip to content

Clinical trials

Thyroid Cancer, Papillary trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20112
20152
20161
20172
20181
20191
20212
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Enrolling by invitation1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University3
Eli Lilly and Company2
Hoffmann-La Roche2
Seoul National University Hospital2
Day One Biopharmaceuticals, Inc.1
Dong Jun Lim1
Exelixis1
National Cancer Center, Korea1
National Cancer Centre, Singapore1
Samsung Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary15
Thyroid Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Head and Neck Neoplasms5
Carcinoma, Medullary4
Breast Neoplasms3
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Colonic Neoplasms3
Colorectal Neoplasms3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.